Your browser doesn't support javascript.
loading
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.
Kevin, Richard C; Mirlohi, Somayeh; Manning, Jamie J; Boyd, Rochelle; Cairns, Elizabeth A; Ametovski, Adam; Lai, Felcia; Luo, Jia Lin; Jorgensen, William; Ellison, Ross; Gerona, Roy R; Hibbs, David E; McGregor, Iain S; Glass, Michelle; Connor, Mark; Bladen, Chris; Zamponi, Gerald W; Banister, Samuel D.
Afiliación
  • Kevin RC; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.
  • Mirlohi S; School of Pharmacy, The University of Sydney, NSW 2006, Australia.
  • Manning JJ; Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia.
  • Boyd R; Department of Pharmacology and Toxicology, University of Otago, Dunedin 9016, New Zealand.
  • Cairns EA; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.
  • Ametovski A; School of Chemistry, The University of Sydney, NSW 2006, Australia.
  • Lai F; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.
  • Luo JL; School of Psychology, The University of Sydney, NSW 2006, Australia.
  • Jorgensen W; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.
  • Ellison R; School of Chemistry, The University of Sydney, NSW 2006, Australia.
  • Gerona RR; School of Pharmacy, The University of Sydney, NSW 2006, Australia.
  • Hibbs DE; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.
  • McGregor IS; School of Psychology, The University of Sydney, NSW 2006, Australia.
  • Glass M; School of Chemistry, The University of Sydney, NSW 2006, Australia.
  • Connor M; Clinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, California 94143, United States.
  • Bladen C; Clinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, California 94143, United States.
  • Zamponi GW; School of Pharmacy, The University of Sydney, NSW 2006, Australia.
  • Banister SD; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, NSW 2050, Australia.
ACS Chem Neurosci ; 13(9): 1395-1409, 2022 05 04.
Article en En | MEDLINE | ID: mdl-35442021
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cannabinoides / Canales de Calcio Tipo T / Hipotermia Límite: Animals Idioma: En Revista: ACS Chem Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cannabinoides / Canales de Calcio Tipo T / Hipotermia Límite: Animals Idioma: En Revista: ACS Chem Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Australia